About RedDress
RedDress is a company based in Ponte Vedra Beach (United States) founded in 2009 by Alon Kushnir and Igal Kushnir. RedDress has raised $26 million across 1 funding round from investors including Athos Therapeutics, HCS Capital and Ragnar. RedDress offers products and services including ActiGraft PRO. RedDress operates in a competitive market with competitors including Imbed Biosciences, Cresilon, Kane Biotech, Alafair Biosciences and Lohmann & Rauscher, among others.
- Headquarter Ponte Vedra Beach, United States
- Founders Alon Kushnir, Igal Kushnir
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Reddress Usa Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$26 M (USD)
in 1 rounds
-
Latest Funding Round
$26 M (USD), Series D
May 24, 2023
-
Investors
Athos Therapeutics
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RedDress
RedDress offers a comprehensive portfolio of products and services, including ActiGraft PRO.
Autologous system for treating chronic, non-healing wounds using blood.
People of RedDress
Unlock access to complete
Funding Insights of RedDress
RedDress has successfully raised a total of $26M through 1 strategic funding round. The most recent funding activity was a Series D round of $26 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in RedDress
RedDress has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Athos Therapeutics, HCS Capital and Ragnar.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
HCS Capital is engaged in venture capital investments in technology companies.
|
Locked | Locked | Locked | |
|
AI-based therapeutics for autoimmune diseases are developed.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for RedDress
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RedDress
Investment portfolio details for RedDress
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RedDress
Detailed financials for RedDress
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Reddress Comparisons
Peer comparison for RedDress
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RedDress
RedDress operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imbed Biosciences, Cresilon, Kane Biotech, Alafair Biosciences and Lohmann & Rauscher, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanotech-based wound care products are developed and provided.
|
|
| Locked | Locked | Locked |
Developer of hemostatic products for wound care
|
|
| Locked | Locked | Locked |
Therapeutic solutions for biofilm prevention and removal are developed.
|
|
| Locked | Locked | Locked |
Biomaterials and devices for internal wound healing are developed.
|
|
| Locked | Locked | Locked |
Dressing materials and medical devices
|
|
| Locked | Locked | Locked |
Nanotech-based antibacterial nanoparticles for wound dressings are provided.
|
Detailed competitors of RedDress
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Reddress
Complete news archive for RedDress
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RedDress
RedDress was founded in 2009 and raised its 1st funding round 14 years after it was founded.
RedDress is headquartered in Ponte Vedra Beach, United States. It is registered at Ponte Vedra Beach, Florida, United States.
Alon Kushnir is the current CEO of RedDress. They have also founded this company.
RedDress is a funded company, having raised a total of $26M across 1 funding round to date.
RedDress was founded in 2009 and is based in Ponte Vedra Beach, United States. Operations are focused on the medical device sector, specifically wound care solutions. The ActiGraft dressing is developed from a patients blood clot to form a fibrin matrix, which acts as a protective barrier and facilitates healing processes. Autologous technologies are utilized to support clinical wound management across healthcare settings.
RedDress's top competitors include Imbed Biosciences, Cresilon and Kane Biotech.
RedDress offers ActiGraft PRO.
RedDress has 3 investors. Key investors include Athos Therapeutics, HCS Capital, and Ragnar.